Forte Biosciences (FBRX) Other financing activities (2020 - 2026)

Forte Biosciences (FBRX) has 7 years of Other financing activities data on file, last reported at $101000.0 in Q1 2026.

• On a quarterly basis, Other financing activities rose 1022.22% year-over-year to $101000.0 in Q1 2026; TTM through Mar 2026 was $110000.0, a 90.2% decrease from a year earlier, with the FY2025 full-year figure at $18000.0, down 98.39% from the prior year.
• Other financing activities for Q1 2026 stood at $101000.0, up from $16000.0 in the prior quarter.
• Over the last five years, Other financing activities for FBRX reached as high as $1.1 million in Q4 2024 and fell as low as -$8000.0 in Q3 2024.
• Historically, Other financing activities has averaged $165300.0 across 5 years, with a median of $31000.0 in 2022.
• Across the five-year window, Other financing activities increased 12.5% in 2025 and soared 1022.22% in 2026, its largest moves.
• Year by year, Other financing activities stood at $110000.0 in 2022, then jumped by 133.64% to $257000.0 in 2023, then jumped by 336.19% to $1.1 million in 2024, then plunged by 98.57% to $16000.0 in 2025, then soared by 531.25% to $101000.0 in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $101000.0 in Q1 2026, $16000.0 in Q3 2025, and -$7000.0 in Q2 2025.